Encompass Health Raises FY2026 Adj EPS Guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.365B-$6.465B to $6.375B-$6.470B vs $6.423B Est

Benzinga Newsdesk www.benzinga.com Positive 76.1%

Neg 0% Neu 0% Pos 76.1%

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.365 billion-$6.465 billion to $6.375 billion-$6.470 billion vs $6.423 billion estimate.